Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 827-840 , October 2007

Measuring disability and quality of life in established rheumatoid arthritis

  • Tore K. Kvien, MD, PhD (Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Rheumatology, Diakonhjemmet Hospital, Box 23 Vinderen, N-0319 Oslo, Norway. Tel.: +47 22 45 17 50; Fax: +47 22 45 17 78.

References 

  1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358:903–911
  2. Kosinski M, Kujawski SC, Martin R, et al. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. The American Journal of Managed Care. 2002;8:231–240
  3. Leonardi M, Bickenbach J, Ustun TB, et al. The definition of disability: what is in a name?. Lancet. 2006;368:1219–1221
  4. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17:13–35
  5. Ward MM. Outcome measurement: health status and quality of life. Current Opinion in Rheumatology. 2004;16:96–101
  6. Kvien TK, Uhlig T. Quality of life in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2005;34:333–341
  7. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30:473–483
  8. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications. Health and Quality of Life Outcomes. 2003;1:20
  9. Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clinical and Experimental Rheumatology. 2005;23:S14–S18
  10. Uhlig T, Haavardsholm EA, Kvien TK. Comparison of the Health Assessment Questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006;45:454–458
  11. Pincus T, Summey JA, Soraci SA, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis and Rheumatism. 1983;26:1346–1353
  12. Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis and Rheumatism. 1999;42:2220–2230
  13. Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis and Rheumatism. 2004;50:3296–3305
  14. Wolfe F. Why the HAQ-II can be an effective substitute for the HAQ. Clinical and Experimental Rheumatology. 2005;23:S29–S30
  15. Wolfe F, Michaud K, Pincus T. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis. The Journal of Rheumatology. 2005;32:1261–1266
  16. Pincus T. Rheumatology function tests: quantitative physical measures to monitor morbidity and predict mortality in patients with rheumatic diseases. Clinical and Experimental Rheumatology. 2005;23:S85–S89
  17. Odegard S, Landewe R, van der HD, et al. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis and Rheumatism. 2006;54:68–75
  18. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics. 2002;21:271–292
  19. Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clinical Rheumatology. 2000;19:195–199
  20. Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. Journal of Clinical Epidemiology. 1998;51:1077–1086
  21. Kvien TK, Uhlig T. The Oslo experience with arthritis registries. Clinical and Experimental Rheumatology. 2003;21:S118–S122
  22. Houssien DA, McKenna SP, Scott DL. The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. British Journal of Rheumatology. 1997;36:69–73
  23. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. The Journal of the Royal College of General Practitioners. 1985;35:185–188
  24. Bergner M, Bobbitt RA, Pollard WE, et al. The sickness impact profile: validation of a health status measure. Medical Care. 1976;14:57–67
  25. EuroQol–a new facility for the measurement of health-related quality of life. The EuroQol Group Health Policy. 1990;16:199–208
  26. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72
  27. Rasanen P, Roine E, Sintonen H, et al. Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care. 2006;22:235–241
  28. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Annals of Medicine. 2001;33:328–336
  29. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health and Quality of Life Outcomes. 2003;1:54
  30. Hewlett S, Carr M, Ryan S, et al. Outcomes generated by patients with rheumatoid arthritis: how important are they?. Musculoskeletal care. 2005;3:131–142
  31. Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. The Journal of Rheumatology. 2004;31:1896–1902
  32. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis and Rheumatism. 1980;23:146–152
  33. Mason JH, Anderson JJ, Meenan RF. A model of health status for rheumatoid arthritis. A factor analysis of the Arthritis Impact Measurement Scales. Arthritis and Rheumatism. 1988;31:714–720
  34. Meenan RF, Mason JH, Anderson JJ, et al. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis and Rheumatism. 1992;35:1–10
  35. Guillemin F, Coste J, Pouchot J, et al. The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group. Arthritis and Rheumatism. 1997;40:1267–1274
  36. Haavardsholm EA, Kvien TK, Uhlig T, et al. A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients. The Journal of Rheumatology. 2000;27:2810–2816
  37. de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. British Journal of Rheumatology. 1997;36:878–883
  38. Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. British Journal of Rheumatology. 1997;36:884–888
  39. Tijhuis GJ, de Jong Z, Zwinderman AH, et al. The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford). 2001;40:1112–1119
  40. Eberhardt K, Duckberg S, Larsson BM, et al. Measuring health related quality of life in patients with rheumatoid arthritis–reliability, validity, and responsiveness of a Swedish version of RAQoL. Scandinavian Journal of Rheumatology. 2002;31:6–12
  41. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis and Rheumatism. 2003;48:1530–1542
  42. Marra CA, Rashidi AA, Guh D, et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?. Quality of Life Research. 2005;14:1333–1344
  43. Marra CA, Woolcott JC, Kopec JA, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science & Medicine. 2005;60:1571–1582
  44. Marra CA, Esdaile JM, Guh D, et al. A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Medical Care. 2004;42:1125–1131
  45. Kaplan RM, Groessl EJ, Sengupta N, et al. Comparison of measured utility scores and imputed scores from the SF-36 in patients with rheumatoid arthritis. Medical Care. 2005;43:79–87
  46. riza-Ariza R, Hernandez-Cruz B, Carmona L, et al. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. Arthritis and Rheumatism. 2006;55:751–756
  47. Doan QV, Chiou CF, Dubois RW. Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis. Journal of Managed Care Pharmacy. 2006;12:555–569
  48. Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Medical Care. 2003;41:791–801
  49. Kirwan JR, Hewlett SE, Heiberg T, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis–progress at OMERACT 7. The Journal of Rheumatology. 2005;32:2250–2256
  50. Kirwan JR, Ahlmen M, de WM, et al. Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment. The Journal of Rheumatology. 2005;32:2246–2249
  51. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for Outcome Measures in Rheumatology. The Journal of Rheumatology. 1998;25:198–199
  52. Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis and Rheumatism. 2002;47:391–397
  53. Verhoeven AC, Boers M, van der LS. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis. The Journal of Rheumatology. 2000;27:2801–2809
  54. Wolfe F, Michaud K, Pincus T. A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II). The Journal of Rheumatology. 2005;32:2410–2415
  55. Athale N, Sturley A, Skoczen S, et al. A web-compatible instrument for measuring self-reported disease activity in arthritis. The Journal of Rheumatology. 2004;31:223–228
  56. Mosley-Williams A, Williams CA. Validation of a computer version of the American College of Rheumatology patient assessment questionnaire for the autonomous self-entry of self-report data in an urban rheumatology clinic. Arthritis and Rheumatism. 2004;50:332–333
  57. Kvien TK, Mowinckel P, Heiberg T, et al. Performance of health status measures with a pen based personal digital assistant. Annals of the Rheumatic Diseases. 2005;64:1480–1484
  58. Heiberg T, Kvien TK, Dale O, et al. Daily health status registration (patient diary) in patients with rheumatoid arthritis: a comparison between personal digital assistant and paper-pencil format. Arthritis and Rheumatism. 2007;57:454–460
  59. Greenwood MC, Doyle DV, Ensor M. Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis?. Annals of the Rheumatic Diseases. 2001;60:344–348
  60. Kvien TK. Epidemiology of disability in rheumatoid arthritis. Rheumatology (Oxford). 2002;41:121–123

PII: S1521-6942(07)00060-5

doi: 10.1016/j.berh.2007.05.004

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 827-840 , October 2007

Article Tools